Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03304288
Brief Title: The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

First Submitted : October 3, 2017
First Submitted that Met QC Criteria : October 3, 2017
First Posted : October 9, 2017

Last Update Submitted that Met QC Criteria : January 16, 2021
Last Update Posted : January 20, 2021